Randomized clinical trials remain the gold standard for establishing a medication's effects, producing the evidence by which ...

First patients dosed in budoprutug PrisMN Phase 2 trial in pMN, with initial data expected second half 2026 Dosing ongoing in ...

Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical oncology innovator advancing late-stage development of investigational first-in-class WEE1 inhibitor azenosertib as a biomarker-driven treatment ...

Traditional trial start-up workflows often follow a sequential path, from feasibility to contracting, then regulatory ...

Via well-designed AI tools and workflows, trial sponsors are aiming to unify cross-functional data ecosystems to enable a ...

Background Extensions to Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) and Consolidated Standards of Reporting Trials (CONSORT) reporting recommendations specifically for ...

Just like the moment a mosquito bites, the shot of dengue virus I received in my arm was so quick and painless that afterward I wasn't even sure it happened at all. A few years ago, I wrote a story ...

Please provide your email address to receive an email when new articles are posted on . AIM-MASH AI Assist is the first AI drug development tool to be qualified by the FDA. The tool is designed to ...

As 2026 approaches, the clinical research and development landscape is evolving beyond traditional scientific innovation with strategic, operational and technological transformation converging to ...

Lizzy Lawrence leads STAT’s coverage of the Food and Drug Administration. She was previously a medical devices reporter. You can reach Lizzy on Signal at lizzylaw.53. WASHINGTON — The Food and Drug ...

Dodd indicated, "We anticipate having vaccine available for clinical evaluation early next year," referencing GEO-MVA. Further, "Our priorities and anticipated milestones for 2025 through 2026 remain ...

A New York Times health reporter explains what clinical trials are, why they are important and how they can help inform us. Credit...Ricardo Tomás Supported by By Nina Agrawal Nina Agrawal is a health ...